• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE TIGRIS® VASCULAR STENT; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE TIGRIS® VASCULAR STENT; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number PHB050402
Device Problems Detachment Of Device Component (1104); Material Separation (1562)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 08/26/2017
Event Type  malfunction  
Manufacturer Narrative
The review of the manufacturing records verified that this lot met all pre-release specifications.(b)(4).
 
Event Description
The patient was presented with an embolism in the upper limb which was intended to be treated with a gore® tigris® vascular stent.The medical device was inserted through a 7fr introducer sheath and advanced over a 0.035 guidewire.It was stated that the patient did not show any calcification or tortuosity of the vessels.It was reported to gore that the gore® tigris® vascular stent was successfully implanted within the femoral artery / popliteal artery.Anyhow it was stated that some force was experienced dewing the deployment mechanism.After the delivery system was removed from the patient¿s vessel, a visual inspection indicated that the distal catheter shaft portion of the medical device was detached.The performed angiography specified that the separated catheter shaft was still on the guidewire.It was stated that the separated portion was retrieved by using a snare device and removed successfully.A second gore® tigris® vascular stent was implanted to finish the procedure.
 
Manufacturer Narrative
The device was returned for evaluation.When physically evaluated upon return, the following observations were made: the device was kinked at multiple locations along the catheter, including near the strain relief.The inner shaft was severed 118mm from the distal end of the tip.The edge of the distal segment of the inner shaft was smooth.The remainder of the inner shaft was still intact within the outer sheath.The edge of the proximal segment of the inner shaft was smooth.The location of the severance in the inner shaft is consistent with the location of a cutting step in the manufacturing process, in which a deployment tube component is roll cut using a razor blade.During this step, tooling is inserted inside the tube component to protect the inner shaft.Omission of this tooling at the cutting step could result in the inner shaft severance observed in this event.Investigation of manufacturing controls, maintenance records of the tooling, and associate training did not reveal any inconsistencies in the production of this device, and no definitive root cause could be confirmed for this event.The process step was reviewed and no systemic issue was identified.Previous tigris complaints were reviewed for the findings of this investigation, and no other complaints with observations consistent with this issue were identified.This issue is an isolated event that has not been observed historically in the manufacture of tigris devices.Tigris complaints will continue to be monitored for this issue.(b)(4).
 
Manufacturer Narrative
Date of event was corrected.Check box was selected that medical device is available for evaluation + date when the device was returned.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE TIGRIS® VASCULAR STENT
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL CENTRAL B/P
1500 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
barbara ulrich
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key6899868
MDR Text Key88016755
Report Number2017233-2017-00504
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
P160004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 11/20/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/28/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/18/2019
Device Catalogue NumberPHB050402
Device Lot Number15696369
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/13/2017
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/19/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age60 YR
-
-